Skip to main content
Premium Trial:

Request an Annual Quote

One More Enters the Fray

Pathway Genomics is jumping into the direct-to-consumer genetic testing market, reports Agence France Presse. According to the company website, the health test costs $249 and will genotype customers for risk markers for over 90 diseases, carrier status for some diseases, drug responses, and inheritable traits (such as eye color), while the ancestry test is $199, though both can be purchased simultaneously for $348. Pathway Genomics will also have genetic counselors on staff. "Our goal is to keep a low cost and make this test available to anyone," founder and CEO Jim Plante tells AFP. "I always felt that consumers didn't have direct access to genetic information in a way that was cost effective."

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.